MabCure, Inc.
MBCI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -141.9% | – | – | – |
| Other Income/Exp. Net | -$12 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$12 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$1 | -$1 | -$1 |
| % Margin | -2,490.3% | – | – | – |
| EPS | -0.2 | -0.023 | -0.023 | -0.012 |
| % Growth | -765.8% | -0.4% | -87% | – |
| EPS Diluted | -0.2 | -0.023 | -0.023 | -0.012 |
| Weighted Avg Shares Out | 64 | 62 | 60 | 43 |
| Weighted Avg Shares Out Dil | 64 | 62 | 60 | 43 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$12 | -$1 | -$1 | -$1 |
| % Margin | -2,409.1% | – | – | – |